Literature DB >> 21307656

Malignant characteristics of circulating tumor cells and corresponding primary tumor in a patient with esophageal squamous cell carcinoma before and after surgery.

Chuanli Ren1, Ping He, Jinqiang Zhang, Zhaoxu Zheng, Yuanyuan Qiao, Xiaohang Zhao.   

Abstract

We report the malignant characteristics of circulating tumor cells (CTCs) and the corresponding molecular features of the primary tumor in a patient with esophageal squamous cell carcinoma (ESCC). A 70-year-old male patient was diagnosed with TNM stage T3N0M0 ESCC. Before surgery, seven intact CTCs and 12 CTCs with a fragmented membrane were detected in 7.5 mL of peripheral blood by immunofluorescence staining. One week after radical resection of the primary tumor, four CTCs were identified in 7.5ml peripheral blood. All CTCs were confirmed as having a malignant phenotype by chromosomal analysis and routine cell staining. Ninety percent of the CTCs were found to have polysomic chromosomes 8 and 20 by fluorescence in situ hybridization (FISH). Immunofluorescence analysis showed that all of the primary tumor cells detected were cytokeratin8/18/19 (CK8/18/19)-positive, but only 1% were CD133-positive. The serum CA19-9 and CEA level were normal in the process of diseases. The patient died 6 months after surgery as a result of lung metastases and other complications. The results of this study suggest that the dynamics and malignant characteristics of both CTCs and the corresponding primary tumor during the disease process may predict tumor burden and the risk of relapse and metastasis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21307656     DOI: 10.4161/cbt.11.7.14950

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  8 in total

1.  Hydroxyethyl starch 200/0.5 decreases circulating tumor cells of colorectal cancer patients and reduces metastatic potential of colon cancer cell line through inhibiting platelets activation.

Authors:  Hua Liang; Chengxiang Yang; Bin Zhang; Hanbing Wang; Hongzhen Liu; Zhenlong Zhao; Zhiming Zhang; Xianjie Wen; Xiaohong Lai
Journal:  Med Oncol       Date:  2015-04-02       Impact factor: 3.064

2.  Monitoring disease progression and treatment efficacy with circulating tumor cells in esophageal squamous cell carcinoma: A case report.

Authors:  Yuan-Yuan Qiao; Kai-Xuan Lin; Ze Zhang; Da-Jin Zhang; Cheng-He Shi; Ming Xiong; Xiu-Hua Qu; Xiao-Hang Zhao
Journal:  World J Gastroenterol       Date:  2015-07-07       Impact factor: 5.742

3.  Increased plasma microRNA and CD133/CK18-positive cancer cells in the pleural fluid of a pancreatic cancer patient with liver and pleural metastases and correlation with chemoresistance.

Authors:  Chuanli Ren; Hui Chen; Chongxu Han; Daxin Wang; Deyuan Fu
Journal:  Oncol Lett       Date:  2012-07-13       Impact factor: 2.967

4.  Clinical significance of phenotyping and karyotyping of circulating tumor cells in patients with advanced gastric cancer.

Authors:  Yilin Li; Xiaotian Zhang; Sai Ge; Jing Gao; Jifang Gong; Ming Lu; Qiyue Zhang; Yanshuo Cao; Daisy Dandan Wang; Peter Ping Lin; Lin Shen
Journal:  Oncotarget       Date:  2014-08-30

5.  Significant prognostic value of circulating tumor cells in esophageal cancer patients: A meta-analysis.

Authors:  Shuyu Wang; Hongyang Du; Guixia Li
Journal:  Oncotarget       Date:  2017-02-28

6.  Prognostic value of circulating tumor cells in the peripheral blood of patients with esophageal squamous cell carcinoma.

Authors:  Yuanyuan Qiao; Jun Li; Chenghe Shi; Wei Wang; Xiuhua Qu; Ming Xiong; Yulin Sun; Dandan Li; Xiaohang Zhao; Dajin Zhang
Journal:  Onco Targets Ther       Date:  2017-03-03       Impact factor: 4.147

7.  Clinical significance of tumor cells in the peripheral blood of patients with esophageal squamous cell carcinoma.

Authors:  Lu Han; Yun-Jie Li; Wei-Di Zhang; Ping-Ping Song; Hao Li; Sheng Li
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

8.  Correlation of CA19-9 and P57 (KiP2) Expression with Tumor Grade and Invasive Front in Oral Squamous Cell Carcinoma.

Authors:  Fatemeh Mashhadiabbas; Moones Rajabi; Mohammad Javad KharaziFard; Hamidreza Moslemi
Journal:  J Dent (Shiraz)       Date:  2018-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.